Proteome Sciences PLC (PRM) — Capital Reinvestment Ratio
Proteome Sciences PLC (PRM) has a Capital Reinvestment Ratio of 0.05x as of December 2025, meaning it reinvests 0% of its operating cash flow (GBX851.00K) in capital expenditures (GBX39.00K). Check Proteome Sciences PLC tangible book value ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Proteome Sciences PLC Capital Reinvestment Ratio (2010–2022)
This chart tracks Proteome Sciences PLC's Capital Reinvestment Ratio across 6 annual periods. For the full cash flow conversion analysis, see PRM operating cash flow.
Annual Capital Reinvestment Ratio for Proteome Sciences PLC (2010–2022)
Year-by-year Capital Reinvestment Ratio for Proteome Sciences PLC from 2010 to 2022. See how much free cash does Proteome Sciences PLC generate to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (GBX) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2022 | 815.89x | GBX2.14 Million | GBX1.75 Billion | ▼ -62.4% |
| 2021 | 2168.98x | GBX793.00K | GBX1.72 Billion | ▲ +159.3% |
| 2020 | 836.39x | GBX1.58 Million | GBX1.32 Billion | ▲ +3186498.5% |
| 2017 | 0.03x | GBX55.47 Billion | GBX1.46 Billion | ▼ -36.5% |
| 2015 | 0.04x | GBX46.63 Billion | GBX1.93 Billion | ▼ -73.8% |
| 2010 | 0.16x | GBX4.00 Million | GBX631.00K | — |